Funding for this research was provided by:
U.S. Department of Veterans Affairs
Article History
Received: 26 February 2024
Accepted: 27 August 2024
First Online: 11 September 2024
Competing interests
: Y.X. and Z.A.-A. report consulting (uncompensated) for Pfizer. Y.X. reports consulting for Guidepoint. Z.A.-A. reports consulting for Gilead Sciences and Tonix Pharmaceuticals. All other authors declare no competing interests.Funding/Support: This study used data from the US Department of Veterans Affairs (VA). This research was funded by the VA (Z.A.A.). Role of the Funder/Sponsor: The VA had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.